BIO3 RESEARCH Logo (USPTO, 15.03.2010)
USPTOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die US-Marke BIO3 RESEARCH wurde als Wort-Bildmarke am 15.03.2010 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 31.01.2012 im Markenregister eingetragen.
Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".
| Markenform | Wort-Bildmarke |
| Aktenzeichen | 77959249 |
| Registernummer | 4092757 |
| Anmeldedatum | 15. März 2010 |
| Veröffentlichungsdatum | 15. November 2011 |
| Eintragungsdatum | 31. Januar 2012 |
Markeninhaber
Corso Venezia, 24
20121 Milan
IT
20121 Milan
IT
Markenvertreter
Waren und Dienstleistungen
5
Biological preparations for medical purposes for the treatment of cardiovascular, dermatological, oncological, ocular, renal and immune system related diseases and disorders; biological preparations for medical purposes for the treatment of anaemia and oxidative stress from haemodialysis and from whatever origin; biological preparations for medical purposes for the treatment of wounds, burns and bedsores, damaged skin and tissue; biological preparations for medical purposes for tissue and bone matrix regeneration, connective tissue repair, and cartilage repair; biological preparations for medical purposes for the treatment of diseases related to HMGB1 protein over-expression and HMGB1 biological properties; biological preparations for medical purposes for the treatment of restenosis and atherosclerosis; biological preparations for medical purposes for the treatment of psoriasis; pharmaceutical preparations and substances for the treatment of cardiovascular, dermatological, oncological, ocular, renal and immune system related diseases and disorders; pharmaceutical preparations for the treatment of oxidative stress from haemodialysis; pharmaceutical preparations and substances for the treatment of wounds, burns and bedsores, damaged skin and tissue; pharmaceutical preparations and substances for the tissue and bone matrix regeneration, connective tissues repair, cartilage repair; therapeutic pharmaceutical agents for the treatment of diseases related to HMGB1 protein over-expression and HMGB1 biological properties; pharmaceutical preparations and substances for the treatment of restenosis and atherosclerosis; pharmaceutical preparations for the treatment of psoriasis; biological preparations for medical purposes for cloning and their variant DNA recombinant
42
Scientific research in the biopharmaceutical field, namely, focused in the areas of cardiovascular disorders, such as restenosis, atherosclerosis and arterial stenosis, connective tissue and tissue regeneration such as wound healing, cartilage repair, bone matrix regeneration, burns and bedsores and renal and skin diseases; research in the oncological field; medical and scientific research, namely, conducting clinical trials and clinical studies
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
ID: 1377959249